Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IV minocycline for acute stroke
ACTRN12612000237886Phase 2Completed
- Sponsor
- Sir Charles Gairdner Hospital
- Start
- Feb 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of minocycline in ischemic stroke and brain hemorrhage (ICH) (2 arms), sponsored by Sir Charles Gairdner Hospital. Primary endpoint: Good neurological outcome. Started Feb 2010; status: completed.
02
Drugs
minocycline
03
Conditions
ischemic strokebrain hemorrhage (ICH)
Beyond the preview
Go deeper on ACTRN12612000237886.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12612000237886.